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Accepted 10 September 2012A 36-year-old, gravida 2, para 1 woman underwent
amniocentesis at 17 weeks of gestation because of advanced
maternal age. Cytogenetic analysis revealed a small proximal
deletion of chromosome 10q. Array comparative genomic
hybridization (aCGH) using CytoChip Oligo array (Blue-
Gnome, Cambridge, UK) on cultured amniocytes revealed
a 12.4-Mb deletion at chromosome 10q11.21e10q21.1 or arr
10q11.21q21.1 (45,525,726e57,919,309)1 (NCBI, build 36,
March 2006) (Fig. 1). The prenatal ultrasound findings were
unremarkable. The parental karyotypes were normal. aCGH
analysis of the parental blood did not reveal any deletion at
chromosome 10q.
The woman underwent a second amniocentesis at 21 weeks
of gestation for confirmation. aCGH using Human CGH
3720KWhole-GenomeTiling v3.0Array (RocheNimbleGen,
Madison, WI, USA) on uncultured amniocytes revealed
a 12.4-Mb deletion at chromosome 10q11.21e10q21.1 or arr
10q11.21q21.1 (45,487,499e57,962,499)1 (NCBI, build 36,
March 2006). Conventional cytogenetic analysis revealed
a karyotype of 46,XY,del(10)(q11.21q21.1) (Fig. 2). The
parents elected to terminate the pregnancy, and a 942-g male
fetus was delivered at 24 weeks of gestation with no apparent
phenotypic abnormalities.* Corresponding author. Department of Obstetrics and Gynecology, Mackay
Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan.
E-mail address: cpc_mmh@yahoo.com (C.-P. Chen).
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http://dx.doi.org/10.1016/j.tjog.2012.09.032The present case had a 12.4-Mb deletion at chromosome
10q11.21/ q21.1 encompassing at least 86 genes, including
CHAT, SLC18A3, ERCC6, MSMB, PCDH15, and MBL2,
which are known to contribute to human disorders. CHAT
(OMIM 118490) encodes choline acetyltransferase, and
compound heterozygous or homozygous mutations in CHAT
can cause congenital myasthenic syndrome associated with
episodic apnea (OMIM 254210) [1,2].
SLC18A3 (OMIM 600336) encodes vesicular acetylcholine
transferase (VACHT). In a study of Vacht knockdown homozy-
gous mice, Lara et al [3] found that the Vacht/mice displayed
dysautonomia due to reduced cholinergic neurotransmission.
ERCC6 (OMIM 609413) is involved in the nucleotide
excision repair pathway and is associated with autosomal
recessive type B Cockayne syndrome (OMIM 133540) [4],
autosomal recessive cerebro-oculo-facio-skeletal syndrome
(OMIM 214150) [5], susceptibility to age-related macular
degeneration 5 due to polymorphism of c.-6530C>G
(rs3793784:C>G) SNP in ERCC6 [6], and autosomal reces-
sive UV-sensitive syndrome 1 (OMIM 600630) [7]. ERCC6 is
located at 10q11.23.
Fryns et al [8] first reported a 24-year-old man with late-onset
Cockayne syndrome and an interstitial deletion del(10)
(q11.23q21.2). Ghai et al [9] recently reported a 4.5-year-old girl
withCockayne syndrome, a paternally inherited 5-Mbdeletion at
10q11.22eq11.23 causing a complete deletion of ERCC6 along
with 49 additional genes, and a maternally inherited frameshiftcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. A deletion at region 10q11.21eq21.1 involving a 12.4-Mb segment (arrows) from position 45,525,726 to position 57,919,309 bp is identified by
oligonucleotide-based array comparative genomic hybridization.
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Fig. 1. (Continued)
674 C.-P. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 51 (2012) 672e676mutation ofERCC6. The parents were clinically normal.ERCC6
is also associated with susceptibility to lung cancer (OMIM
211980). Lin et al [10] found that c.-6530CC carriers had a 1.7-
fold excess risk of developing lung cancer comparedwith theCG
or GG genotypes.
MSMB (OMIM 157145) encodes beta-microseminoprotein,
which is a prostatic secretory protein. Thomas et al [11] and
Eeles et al [12] identified single nucleotide polymorphism
rs10993994 in the proximal promoter of the MSMB gene,
which had a significant association with prostate cancer
(hereditary prostate cancer 13; OMIM 611928).
PCDH15 (OMIM 605514) encodes protocadherin 15,
which is expressed in both retina and cochlea. Mutations in
PCDH15 cause Usher syndrome type 1F (OMIM 602083)
[13,14], Usher syndrome type 1D/F (OMIM 601067) [15], and
autosomal recessive deafness 23 (OMIM 609533) [16].
MBL2 (OMIM 154545) encodes mannose-binding protein
or lectin. Mannose-binding protein deficiency is associated
with susceptibility to and recovery from infection, cystic
fibrosis mortality and morbidity, vascular disease, gestational
diabetes mellitus, and preterm delivery [17e21].
Cases with interstitial 10q deletions involving 10q11.2 and
clinical findings have been well reported [8,9,22e33]. Stan-
kiewicz et al [33] suggested that recurrent deletions and
reciprocal duplications of 10q11.21q11.23 including CHAT
and SLC18A3 are likely mediated by complex low-copy
repeats of locus control region (LCR) 10q11.2A to LCR
10q11.2F. In a study of 24 unrelated individuals with deletions
at 10q11.21q11.23, Stankiewicz et al [33] concluded that the
subjects carrying 10q11.21q11.23 deletions may exhibit vari-
able phenotype expressivity, incomplete penetrance, common
clinical features of developmental delay, and/or intellectual
disability, and variable features of hypotonia, sleep apnea,
chronic constipation, gastroesophageal and vesicoureteral
refluxes, epilepsy, ataxia, dysphagia, nystagmus, and ptosis,
which may result from deletion of CHAT and SLC18A3.
Ray et al [22] reported a 1-year-old boy with a karyotype of
46,XY,del(10)(q11q21), mental retardation, significant devel-
opmental delay, facial dysmorphism, limitation of joint
movement, and mild hypotonia. Holden and MacDonald [23]
described the case of a 9-year-old girl with a karyotype of
46,XX,del(10)(q11.2q21), cleft palate, ptosis, developmental
delay, mild hypotonia, deficit in language function, mental
retardation, and seizures. Similarly, Shapiro et al [24] a 5-year-
old girl with an interstitial deletion of 10q11.2/ q22.1 due to
a t(10;13). The girl manifested facial dysmorphism, gross
developmental delay, strabismus, hypoplasia of the right optic
nerve, hypotonia, ventricular septal defect, and flexion defor-
mity of the fingers.
Fryns et al [8] and Ghai et al [9] described patients with
interstitial 10q deletions and Cockayne syndrome. Lobo
et al.’s [25] 12-month-old female patient had a karyotype of
46,XX,del(10)(q11.1q22.1), facial dysmorphism, strabismus,
psychomotor retardation, hypotonia, and ventricular septal
defect. Martucciello et al [26] and Puliti et al [27] reported
a 21-month-old girl with a karyotype of 46,XX,del(10)
(q11.21q21.2) and Hirschsprung disease. Zenger-Hain et al
Fig. 2. Karyotype 46,XY,del(10)(q11.2q21.1). The arrows indicate the breakpoints. The del(10q) chromosome is on the right of the chromosome 10 pair.
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46,XY,del(10)(q11.2q22.1), facial dysmorphism, hypotonia,
postnatal-onset slow growth, short stature, mental retardation,
and subaortic stenosis. Fewtrell et al [29] reported an 8-month-
old girl with a karyotype of 46,XX,del(10)(q11.2q21.2),
meconium ileus, and Hirschsprung disease. Kirchhoff et al
[30] and Bisgaard et al [31] described an aCGH diagnosis of
del(10) (q11.1q21.1) in a 3-month-old girl with mental retar-
dation, facial dysmorphism, and Bohring-Opitz syndrome. The
mother and two siblings had the same deletion but were
unaffected. Chen et al [32] described the prenatal diagnosis of
a de novo 4.9-Mb deletion of 10q11.21/ q11.23 by aCGH in
a fetus with facial dysmorphism.
Cases with no recognizable phenotype have been reported
with interstitial deletions of 10q [33e35]. Derksen et al [34]
reported the prenatal diagnosis of 46,XY,del(10)(q11.2q21.1)
by amniocentesis because of advanced maternal age. The
mother and maternal grandmother carried the same chromo-
some aberration. The parents elected to continue the preg-
nancy, and the baby was normal at age 12 weeks. The deletion
of 10q11.2/ q21.1 presented no phenotypic consequences in
this family. Davis et al [35] described a 29-year-old pheno-
typically normal male with a karyotype of 46,XY,
del(10)(q11.2q21.2)dn. Stankiewicz et al [33] observed
apparently normal carrier parents in 10 of 13 inherited cases
with a 10q11.21q11.23 deletion, and affected carrier parents
with affected carrier siblings in two cases. The variable
expressivity and clinical heterogeneity have been suggested to
be caused by additional genetic and nongenetic modifiers suchas atypical or variable-sized copy number changes and a “two-
hit” model [33].
In summary, we report prenatal diagnosis and mole-
cular cytogenetic characterization of de novo del(10)
(q11.21 / q21.1) in a fetus with no apparently phenotypic
abnormalities. Genetic counseling for prenatally detected
interstitial deletions involving 10q11.2 remains difficult
because no ultrasound abnormalities can be expected, and the
reported cases show phenotypic diversity.
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